Last10K.com

Emmaus Life Sciences, Inc. (EMMA) SEC Filing 10-Q Quarterly report for the period ending Friday, March 31, 2017

Emmaus Life Sciences, Inc.

CIK: 1420031 Ticker: EMMA
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2017
May 12, 2017
Document And Entity Information  
Entity Registrant NameEMMAUS LIFE SCIENCES, INC. 
Entity Central Index Key0001420031 
Document Type10-Q 
Trading SymbolEMMA 
Document Period End DateMar. 31, 2017 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Entity a Well-known Seasoned IssuerNo 
Entity a Voluntary FilerNo 
Entity's Reporting Status CurrentYes 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 34,742,219
Document Fiscal Period FocusQ1 
Document Fiscal Year Focus2017 

View differences made from one quarter to another to evaluate Emmaus Life Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Emmaus Life Sciences, Inc..

Continue

Assess how Emmaus Life Sciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Emmaus Life Sciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets (unaudited)
Consolidated Balance Sheets (unaudited) (parenthetical)
Consolidated Statement Of Changes In Stockholders' Deficit (unaudited)
Consolidated Statements Of Cash Flows (unaudited)
Consolidated Statements Of Comprehensive Loss (unaudited)
Accounts Payable And Accrued Expenses
Accounts Payable And Accrued Expenses (details)
Accounts Payable And Accrued Expenses (tables)
Basis Of Presentation
Commitments And Contingencies
Commitments And Contingencies (details Narrative)
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Geographic Information
Geographic Information (details)
Geographic Information (tables)
Notes Payable
Notes Payable (details 1)
Notes Payable (details 2)
Notes Payable (details 3)
Notes Payable (details Narrative)
Notes Payable (details)
Notes Payable (tables)
Property And Equipment
Property And Equipment (details Narrative)
Property And Equipment (details)
Property And Equipment (tables)
Related Party Transactions
Related Party Transactions (details)
Related Party Transactions (tables)
Stockholders' Deficit
Stockholders' Deficit (details 1)
Stockholders' Deficit (details 2)
Stockholders' Deficit (details Narrative)
Stockholders' Deficit (details)
Stockholders' Deficit (tables)
Subsequent Events
Subsequent Events (details 1)
Subsequent Events (details)
Subsequent Events (tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (details 1)
Summary Of Significant Accounting Policies (details 2)
Summary Of Significant Accounting Policies (details 3)
Summary Of Significant Accounting Policies (details 4)
Summary Of Significant Accounting Policies (details Narrative)
Summary Of Significant Accounting Policies (details)
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (tables)
Ticker: EMMA
CIK: 1420031
Form Type: 10-Q Quarterly Report
Accession Number: 0001104659-17-032256
Submitted to the SEC: Fri May 12 2017 1:41:19 PM EST
Accepted by the SEC: Fri May 12 2017
Period: Friday, March 31, 2017
Industry: Blank Checks

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/emma/0001104659-17-032256.htm